Loading
Rainmed Medical Ltd. - B Stock: price and insider trades · Hong Kong
1 insider bought €1,813 of shares over the last 90 days, the latest by Huo Yunlong, filed 21 Sept 2026.
Rainmed Medical Ltd. - B: what insiders have been doing
Rainmed Medical Ltd. - B is a Health Care company. Its directors and officers file their transactions with HKEX. 3 insiders have disclosed 7 filings since 22 October 2025.
Not one open-market sale was filed. On the buying side, 1 insider reported 5 purchases totalling €12k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 senior executive among the declarants. Biggest ticket of the year: €3,132, bought by Huo Yunlong and made public on 24 October 2025.
The last purchase on record was published on 21 September 2026, which is 33 days ago. The median gap between a trade and its publication by HKEX is 4 days. This delay matters because a trade only becomes useful information once it is public.
For context, the typical company on the same exchange (median of 1,314 companies) published 4 filings over the same period, against 7 filings here. Over the whole record (from 2022), the tally stands at 20 purchases and 7 sales.
Other companies in the same sector with recent insider buying flagged by our signals: UCB. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
38
Thresholds
n/a
Buy Volume
€71,100
20 ops. · all time
Sell Volume
€467,295
7 ops. · all time
Who traded when
BuySaleLyu Yonghui7 sales
Huo Yunlong6 buys
Huo Yunfei1 buy
Since the insiders bought
- -28.3%Entry HK$0.24 · Close at T+90 HK$0.17
- +22.0%Entry HK$0.20 · Close at T+365 HK$0.24
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,200 of 26,286 companies
23.6
score / 100
Value6
Quality41
FCF yld-38%
Earn yld-36%
EV/EBITDA·
ROE-19%
Gross mgn47%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.16
Analyst consensus
Income statement
RevenueHK$19.2M
Gross profitHK$9M47% margin
EBITDA-HK$58.3M-304% margin
Net income-HK$77.1M-285.4% margin
Valuation
P/Book0.6x
Beta0.64
Balance sheet & cash
Market capHK$217.2M
Total debtHK$24.8M
Free Cash Flow-HK$81.5M
Debt / Equity55%
Profitability & ownership
ROE-18.8%
ROA-7.2%
% insiders53.5%
% institutions0.0%
Last declaration on 21 September 2026
Declarations38 total
108,000 shares@ HK$0.1510.0067% mcap11.3% of flowShareXHKGHKEX:DA20260919E00043
Canonical exit: 16 Dec 2026 (T+90)
104,000 shares@ HK$0.2010.0088% mcap38.4% of flowShareXHKGHKEX:DA20260717E00030
Canonical exit: 13 Oct 2026 (T+90)
233,559,800 sharesShareXHKGHKEX:DA20260604E00054
80,000 shares@ HK$0.2220.0052% mcap31.8% of flowShareXHKGHKEX:DA20260506E00013
Canonical exit: 29 Jul 2026 (T+90)
280,000 sharesShareXHKGHKEX:DA20260428E00304
101,000 shares@ HK$0.26518.3% of flowShareXHKGHKEX:DA20260105E00059
Canonical exit: 31 Mar 2026 (T+90)
101,000 shares@ HK$0.2819.5% of flowShareXHKGHKEX:DA20251024E00447
Canonical exit: 22 Jan 2026 (T+90)
3,900,000 shares@ HK$0.355432.4% of flowShareXHKGHKEX:DA20250812E00347
401,000 shares@ HK$0.33883.2% of flowShareXHKGHKEX:DA20250811E00082
674,000 shares@ HK$0.34345.4% of flowShareXHKGHKEX:DA20250808E00242
5,000,000 shares@ HK$0.34240.3% of flowShareXHKGHKEX:DA20250807E00298
1,258,000 shares@ HK$0.33279.8% of flowShareXHKGHKEX:DA20250805E00269
795,000 shares@ HK$0.37117.0% of flowShareXHKGHKEX:DA20250805E00027
200,000 shares@ HK$0.401.9% of flowShareXHKGHKEX:DA20250804E00453
280,000 sharesShareXHKGHKEX:DA20250722E00285
32,287,000 sharesShareXHKGHKEX:DA20250722E00069
233,559,800 sharesShareXHKGHKEX:DA20250716E00043
186,000 shares@ HK$0.19424.3% of flowShareXHKGHKEX:DA20250703E00051
Canonical exit: 28 Sept 2025 (T+90)
200,000 shares@ HK$0.207.9% of flowShareXHKGHKEX:DA20250627E00535
Canonical exit: 25 Sept 2025 (T+90)
100,000 shares@ HK$0.1392.9% of flowShareXHKGHKEX:DA20240905E00071
Canonical exit: 3 Dec 2024 (T+90)
3,000 shares@ HK$0.1350.1% of flowShareXHKGHKEX:DA20240905E00070
Canonical exit: 2 Dec 2024 (T+90)
160,354,000 sharesShareXHKGHKEX:DA20240830E00297
6,220,000 sharesShareXHKGHKEX:DA20240829E00212
300,000 shares@ HK$0.149.1% of flowShareXHKGHKEX:DA20240430E00159
Canonical exit: 28 Jul 2024 (T+90)
47,000 shares@ HK$0.424.2% of flowShareXHKGHKEX:DA20240111E00352
Canonical exit: 10 Apr 2024 (T+90)
25 of 38 declarations
About Rainmed Medical Ltd. - B
Rainmed Medical Ltd. is a company operating in the healthcare and pharmaceutical sector, listed on the Hong Kong Stock Exchange. It focuses on developing innovative medical solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
